PharmaEssentia, a Korean subsidiary of PharmaEssentia, a Taiwanese pharmaceutical company, has obtained a drug business license. The first CEO of PharmaEssentia in Korea is Haksun Moon, former representative of Novartis Korea.

The MFDS granted PharmaEssentia Korea a drug business license as of the 4th. The first factory is located on the 14920th floor of Sejong-daero, Jongno-gu, Seoul.

On the 13th of last month, the company obtained a domestic product license for Besremi (Ropeginterferon alpha-2B), a treatment for rare diseases. Meditip, a licensing agency, was approved because PharmaEssentia was not granted business license.

The drug is said to be manufactured at the Pharm